Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Centre Hospitalier Universitaire de Quebec
Québec, Quebec, Canada
- Charite - Universitaetsmedizin Berlin
Berlin, Germany
- Universitatsklinik - Saarland
Homburg/Saar, Germany
- Kiel Universitatshautklinik
Kiel, Germany
- Klinische Kooperationseinheit Fur Dermatoonkologie (dfkz)
Mannheim, Germany
- Klinikum Rechts Der Isar/technische Universitaet Muenchen
Munich, Germany
- Royal Marsden Hospital - Sutton
London, England, United Kingdom
- John Wayne Cancer Institute at Saint John'S Health Center
Santa Monica, California, United States
- University of Colorado Cancer Center at University of Colorado Health Sciences Center
Aurora, Colorado, United States
- Moffitt Clinic at Tampa General Hospital
Tampa, Florida, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- James Graham Brown Cancer Center at University of Louisville
Louisville, Kentucky, United States
- Ellis Fischel Cancer Center at University of Missouri - Columbia
Columbia, Missouri, United States
- Melanoma Center of St. Louis, Missouri Baptist Medical Center
St Louis, Missouri, United States
- Beth Israel Medical Center
New York, New York, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Comprehensive Cancer Center at Our Lady of Mercy Medical Center
The Bronx, New York, United States
- Hillman Cancer Center at University of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2002
- Primary completion
- —
- Completion
- —
- Last update posted
- 18 Dec 2013
- Registered enrollment
- —
- Registry id
- NCT00039234
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.